[1]
“Formulation and In-vivo Evaluation of Dasatinib-loaded Solid Lipid Nanoparticles”, Int. J. Pharm. Sci. Drug Res., vol. 14, no. 6, pp. 824–832, Nov. 2022, doi: 10.25004/IJPSDR.2022.140621.